21-02-2026 23:21 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Deliverable Volume
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 379.18
NSE Code AUROPHARMA
Dividend Yield % 0.00
Market Cap 673584.68
P/E 31.61
EPS 36.69
Face Value 1  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
20-Feb-2026 28911 11248 38.91
19-Feb-2026 122879 50981 41.49
18-Feb-2026 95224 46140 48.45
17-Feb-2026 88499 37252 42.09
16-Feb-2026 121222 90863 74.96
13-Feb-2026 16694 5174 30.99
12-Feb-2026 14398 6366 44.21
11-Feb-2026 151519 52735 34.80
10-Feb-2026 270367 115083 42.57
09-Feb-2026 24481 11973 48.91
06-Feb-2026 11909 4386 36.83
05-Feb-2026 14132 7348 52.00
04-Feb-2026 50623 18507 36.56
03-Feb-2026 268352 207540 77.34
02-Feb-2026 6613 2026 30.64
01-Feb-2026 25858 12798 49.49
Page 1 of 1
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.